Todd Pieper News Today

Researchers believe personalised medicine and vaccines are probably the next big thing in the quest to reduce cancer deaths

The next big advance in cancer treatment could be a vaccine that can shrink tumors and stop cancer from coming back. Among the targets for the experimental shots: melanoma, pancreatic cancer, breast cancer and lung cancer. The research has reached a turning point, scientists say, with many predicting new cancer vaccine approvals within five years. These are vaccines to treat existing disease but preventing cancer before it starts is another line of vaccine research.

The next big advance in cancer treatment could be a vaccine that can shrink tumors and stop cancer from coming back. Among the targets for the experimental shots: melanoma, pancreatic cancer, breast cancer and lung cancer. The research has reached a turning point, scientists say, with many predicting new cancer vaccine approvals within five years. These are vaccines to treat existing disease but preventing cancer before it starts is another line of vaccine research.

The next big advance in cancer treatment could be a vaccine that can shrink tumors and stop cancer from coming back. Among the targets for the experimental shots: melanoma, pancreatic cancer, breast cancer and lung cancer. The research has reached a turning point, scientists say, with many predicting new cancer vaccine approvals within five years. These are vaccines to treat existing disease but preventing cancer before it starts is another line of vaccine research.

The next big advance in cancer treatment could be a vaccine that can shrink tumors and stop cancer from coming back. Among the targets for the experimental shots: melanoma, pancreatic cancer, breast cancer and lung cancer. The research has reached a turning point, scientists say, with many predicting new cancer vaccine approvals within five years. These are vaccines to treat existing disease but preventing cancer before it starts is another line of vaccine research.

The next big advance in cancer treatment could be a vaccine that can shrink tumors and stop cancer from coming back. Among the targets for the experimental shots: melanoma, pancreatic cancer, breast cancer and lung cancer. The research has reached a turning point, scientists say, with many predicting new cancer vaccine approvals within five years. These are vaccines to treat existing disease but preventing cancer before it starts is another line of vaccine research.

The next big advance in cancer treatment could be a vaccine that can shrink tumors and stop cancer from coming back. Among the targets for the experimental shots: melanoma, pancreatic cancer, breast cancer and lung cancer. The research has reached a turning point, scientists say, with many predicting new cancer vaccine approvals within five years. These are vaccines to treat existing disease but preventing cancer before it starts is another line of vaccine research.

The next big advance in cancer treatment could be a vaccine that can shrink tumors and stop cancer from coming back. Among the targets for the experimental shots: melanoma, pancreatic cancer, breast cancer and lung cancer. The research has reached a turning point, scientists say, with many predicting new cancer vaccine approvals within five years. These are vaccines to treat existing disease but preventing cancer before it starts is another line of vaccine research.

The next big advance in cancer treatment could be a vaccine that can shrink tumors and stop cancer from coming back. Among the targets for the experimental shots: melanoma, pancreatic cancer, breast cancer and lung cancer. The research has reached a turning point, scientists say, with many predicting new cancer vaccine approvals within five years. These are vaccines to treat existing disease but preventing cancer before it starts is another line of vaccine research.

Trip.com Group said on Friday it would pay 50,000 yuan ($6,897.69) to employees for each child they have starting July 1 - the first such initiative by a large private company in China as the country struggles with an ageing population. The company, one of the world's largest online travel agencies, with 400 million users, said it would pay a parental cash subsidy of 10,000 yuan annually for five years for every child born to its employees worldwide. The program will cost about 1 billion yu...